​Human and Statistical Genetics Faculty

   
Page    of 1
  • Arpana Agrawal, Ph.D. - Genetic and environment studies of addictions
  • John P. Atkinson, M.D. - Complement activation and regulation in innate and adaptive immunity
  • Laura J. Bierut, M.D. - Family and genetic studies of psychiatric illnesses and substance dependence (alcoholism, smoking, and cocaine dependence)
  • Ryan Bogdan, Ph.D. - How genetic variation and environmental experience contribute to individual differences in brain function, behavior, and psychopathology
  • Kelly L. Bolton, M.D., Ph.D. - The interplay between inherited genetic variation, environmental factors, and acquired mutations in shaping the earliest stages of carcinogenesis
  • Michael R. Brent, Ph.D. - Computational genomics, human genetics, systems biology, transcriptional regulatory networks
  • Yin Cao, Sc.D., MPH - Novel lifestyle, microbial, and genetic risk factors for lung and gastrointestinal cancers leveraging large-scale clinical and population-based cohorts with deep genetic and phenotypic data
  • Aadel A. Chaudhuri, M.D., Ph.D. - Liquid biopsy cancer detection
  • F. Sessions Cole, M.D. - Genetic lung disease, Surfactant protein B, and rare diseases in infants
  • Megan A. Cooper, M.D., Ph.D. - The biology of natural killer (NK) cells and genetic investigation of primary immune dysregulation syndromes
  • Sharon Cresci, M.D. - Genetic variation in the variable response to pharmacologic treatment (i.e. Pharmacogenomics) of cardiovascular disease; specifically individuals with both diabetes mellitus and coronary artery disease.
  • Carlos Cruchaga, Ph.D. - The goal of my lab is to understand the biology of neurodegeneration by using high-dimensional omic data and functional genomic approaches.
  • Gerald W. Dorn, II, M.D. - Cellular, Molecular, And Genetic Studies Of Cardiac Hypertrophy And Heart Failure
  • Joseph D. Dougherty, Ph.D. - Human Psychiatric Genetics, Mouse Models, Cell Type Specific Gene Expression Profiling, Translation, Astrocytes.
  • Bettina F. Drake, Ph.D., M.P.H. - Identifying preventive strategies to reduce cancer disparities
  • Susan K. Dutcher, Ph.D.
  • John R. Edwards, Ph.D. - Understanding epigenomic abnormalities in breast cancer
  • Stephanie A. Fritz, M.D., MSCI - Asking and answering critical questions to guide clinical practice and ameliorate childhood suffering due to staphylococcal disease
  • C. Charles Gu, Ph.D. - Statistical genetics and bioinformatics, high-dimensional data analysis and complex systems modeling, developing novel methodologies for detecting complex disease genes and characterizing their function
  • Gabriel Haller, Ph.D. - Genetic underpinnings of neurological/neurosurgical disorders
  • Oscar M. Harari, Ph.D. - Identification of "omics" (proteomic, transcriptomic and genetic) factors associated with neurodegeneration
  • Andrew C. Heath, D.Phil. - Genetic studies of alcoholism, smoking and drug dependence, depression, suicidality and anxiety disorders, personality disorders, and methodological research in genetic epidemiology
  • Aimee S. James, Ph.D., M.P.H. - Cancer prevention and control, health disparities and community-based research
  • Sheng Chih (Peter) Jin, Ph.D. - We use human genetic, functional genomic, and bioinformatic approaches to understand the consequence of genetic variants underlying diseases
  • Heather A. Lawson, Ph.D. - Integration of whole-genome sequence with phenotypic data to understand parent-of-origin genetic effects and gene-by-environment interactions
  • Christopher Maher, Ph.D. - Translational Cancer Genomics; Noncoding RNAs
  • Michael A. Province, Ph.D. - Mathematical development of new statistical genetics methodology for complex traits
  • D.C. Rao, Ph.D. - Statistical genetic analysis of cardiovascular disease traits using GxG and GxE interactions
  • John P. Rice, Ph.D. - Statistical genetics; complex disease genetics; methods in statistical genetics
  • Eli Roberson, Ph.D. - Using bench molecular biology, high-throughput sequencing, and bioinformatics to understand human inflammatory / autoimmune disease.
  • Nancy L. Saccone, Ph.D. - Statistical genetics, complex human diseases, analysis methods
  • Matthew J. Silva, Ph.D. - Skeletal mechanobiology; bone strength; osteoporosis; bone fracture, repair & regeneration
  • Nathan Stitziel, M.D., Ph.D. - We try understand the inherited basis underlying cardiovascular disease and leverage insights from our work to improve patient care.
  • Gary D. Stormo, Ph.D. - Computational biology, bioinformatics, protein-DNA interactions, gene regulation
  • Adetunji T. Toriola, M.D., Ph.D. - Associations of metabolic imbalance, inflamation with cancer etiology and survival
  • Tychele N. Turner, Ph.D. - Discovery and characterization of genetic etiological factors involved in neurodevelopmental disorders
  • Ting Wang, Ph.D. - Epigenome evolution and epigenetic determinants of cell fate
  • Mark A. Watson, M.D., Ph.D. - Use of microarray technology and other 'whole-genome' approaches to molecularly classify human malignancies and to identify genetic pathways associated with tumor progression
  • Elizabeth L. Yanik, Ph.D. - My research is focused on investigating the genetic determinants of under-studied musculoskeletal phenotypes, determining the impact of occupational burdens on musculoskeletal disease, and understanding interactions between genetic and non-genetic risk factors for musculoskeletal disease.
   
Page    of 1

Follow us: